Menu
GWAS Study

Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Ikeda M, Okahisa Y, Aleksic B et al.

23594818 PubMed ID
GWAS Study Type
234 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IM
Ikeda M
OY
Okahisa Y
AB
Aleksic B
WM
Won M
KN
Kondo N
NN
Naruse N
AK
Aoyama-Uehara K
SI
Sora I
IM
Iyo M
HR
Hashimoto R
KY
Kawamura Y
NN
Nishida N
MT
Miyagawa T
TM
Takeda M
ST
Sasaki T
TK
Tokunaga K
ON
Ozaki N
UH
Ujike H
IN
Iwata N
Chapter II

Abstract

Summary of the research findings

Methamphetamine (METH) use can provoke psychotic reactions requiring immediate treatment, namely METH-induced psychosis. Although the distinction between METH-induced and primary psychosis is important for understanding their clinical courses, we do not have clear diagnostic procedure by their symptoms. Not only are there similarities between the clinical features of METH-induced psychosis and schizophrenia (SCZ), but there is also epidemiological evidence of a shared genetic risk between 'METH-related' disorders and SCZ, which makes the differentiation of these two conditions difficult. In this study, we conducted a genome-wide association study (GWAS) targeting METH-dependent patients. The METH sample group, used in the METH-dependence GWAS, included 236 METH-dependent patients and 864 healthy controls. We also included a 'within-case' comparison between 194 METH-induced psychosis patients and 42 METH-dependent patients without psychosis in a METH-induced psychosis GWAS. To investigate the shared genetic components between METH dependence, METH-induced psychosis, and SCZ, data from our previous SCZ GWAS (total N=1108) were re-analyzed. In the SNP-based analysis, none of the SNPs showed genome-wide significance in either data set. By performing a polygenic component analysis, however, we found that a large number of 'risk' alleles for METH-induced psychosis are over-represented in individuals with SCZ (Pbest=0.0090). Conversely, we did not detect enrichment either between METH dependence and METH-induced psychosis or between METH dependence and SCZ. The results support previous epidemiological and neurobiological evidence for a relationship between METH-induced psychosis and SCZ. These also suggest that the overlap between genes scored as positive in these data sets can have higher probability as susceptibility genes for psychosis.

193 East Asian ancestry methamphetamine-dependent cases, 41 East Asian ancestry methamphetamine-dependent controls

Chapter III

Study Statistics

Key metrics and study information

234
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.